Worsening renal function in heart failure is less harmful if associated with optimization of heart failure medication: insights from a large Registry.

10 May 2026 (09:30 - 10:15)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Daniela Tomasoni

Spedali Civili, University Of Brescia, Brescia (Italy)

5 More presentations in this session

Presentation thumbnail

Undiagnosed chronic kidney disease, outcomes, and finerenone in heart failure with preserved ejection fraction

Doctor J. Ostrominski (Boston, US)

Abstract Slides

Presentation thumbnail

Care discrepancy in the management of the cardiorenal-metabolic syndrome: real-world analysis of SGLT2 inhibitor use in heart failure, chronic kidney disease, and type 2 diabetes

Miss E. Ziegler (Hamburg, DE)

Abstract Slides Video

Presentation thumbnail

Cardio-kidney-metabolic overlap in patients with severe heart failure: data from the HELP-HF registry

Doctor A. Villaschi (Milan, IT)

Abstract Slides Video

Presentation thumbnail

Clinical impact of renal function deterioration while awaiting heart transplantation in patients bridged with left ventricular assist devices: a multicenter analysis of the UNOS database

Associate Professor R. Asleh (Jerusalem, IL)

Abstract Slides

Presentation thumbnail

Prognostic impact of cardio-renal-metabolic syndrome in HFrEF from an emerging economy

Doctor A. Perez Perez (Mexico City, MX)

Abstract Slides Video

Access the full session

Session thumbnail

Navigating the cardio-renal syndrome (1)

The Event

Event poster

Heart Failure 2026

10 May 2026 09:30 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources